Clinical Trials Browser

Unknown × Neoplasms × avelumab × Clear all

NCT05289856 2024-03-07

Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)

Phase 2 Unknown

Neoplasms

NCT03812796 2019-02-05

EMERGE

Phase 2 Unknown

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms